Cargando…

Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices

BACKGROUND: Myelosuppression is a major dose‐limiting complication of chemotherapy for patients with extensive‐stage small cell lung cancer (ES‐SCLC). The objective was to describe the burden of myelosuppression, treatment patterns, and supportive care use among patients with ES‐SCLC treated with ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hart, Lowell, Ogbonnaya, Augustina, Boykin, Kristen, Deyoung, Kathryn, Bailey, Ray, Heritage, Trevor, Lopez‐Gonzalez, Lorena, Huang, Huan, Gordan, Lucio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166910/ https://www.ncbi.nlm.nih.gov/pubmed/37000119 http://dx.doi.org/10.1002/cam4.5738

Ejemplares similares

Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
por: Goldschmidt, Jerome, et al.
Publicado: (2023)

Piperacillin/tazobactam Induced Myelosuppression
por: Lee, Kirsty Wai Chung, et al.
Publicado: (2009)

Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors
por: Epstein, Robert S., et al.
Publicado: (2020)

TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy
por: Brenet, Fabienne, et al.
Publicado: (2013)

Predictive Model of Chemotherapy-Induced Myelosuppression for Patients with Esophageal Cancer
por: Zheng, Ziming, et al.
Publicado: (2022)

Effects of Traditional Chinese Medicine on Chemotherapy-Induced Myelosuppression and Febrile Neutropenia in Breast Cancer Patients
por: Tian, Huan, et al.
Publicado: (2015)

Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
por: Papanicolas, Lito E., et al.
Publicado: (2021)

Translational Modeling of Drug‐Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor
por: Collins, TA, et al.
Publicado: (2017)

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
por: Kumar, R, et al.
Publicado: (2009)

Myelosuppression by sunitinib is flt-3 genotype dependent
por: van Erp, N P, et al.
Publicado: (2010)

Sleeping through the storm: Preventing myelosuppression with quizartinib
por: Taylor, Samuel J., et al.
Publicado: (2017)

Antineoplastics: Myelosuppression and COVID-19: case report
Publicado: (2020)

Palbociclib: Myelosuppression and gastrointestinal reactions: case report
Publicado: (2022)

Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
por: Otsuka, Yuki, et al.
Publicado: (2020)

H(2)S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets
por: Liu, Huan-Di, et al.
Publicado: (2016)

An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy
por: Baggott, Christina R., et al.
Publicado: (2010)

Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy
por: Matsui, Kaoru, et al.
Publicado: (1996)

Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression
por: Brenet, Fabienne, et al.
Publicado: (2015)

Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
por: Gawade, Prasad L., et al.
Publicado: (2020)

The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
por: Zecha, Judith A. E. M., et al.
Publicado: (2019)

Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review
por: Pan, Linlin, et al.
Publicado: (2020)

Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
por: Epstein, Robert S, et al.
Publicado: (2021)

Promotion of Myelopoiesis in Myelosuppressed Mice by Ganoderma lucidum Polysaccharides
por: Zhu, Xiao-Ling, et al.
Publicado: (2012)

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk
por: Nguyen, Christine M., et al.
Publicado: (2011)

Multiple drugs: Aseptic Meningitis and myelosuppression: case report
Publicado: (2022)

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.
por: Dercksen, M. W., et al.
Publicado: (1993)

Infusion of allogeneic umbilical cord blood hematopoietic stem cells in patients with chemotherapy-related myelosuppression
por: YAO, YI, et al.
Publicado: (2014)

Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
por: Gorchynski, Julie, et al.
Publicado: (2008)

Hematopoietic Effects of Paeoniflorin and Albiflorin on Radiotherapy-Induced Myelosuppression Mice
por: Zhu, Yingli, et al.
Publicado: (2016)

New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression
por: Gupta, Vineet, et al.
Publicado: (2013)

Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?
por: Rafi, Mohammad, et al.
Publicado: (2018)

ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression
por: Drenberg, CD, et al.
Publicado: (2016)

Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia
por: Jost, Felix, et al.
Publicado: (2019)

An Early Myelosuppression in the Acute Mouse Sepsis Is Partly Outcome-Dependent
por: Skirecki, Tomasz, et al.
Publicado: (2021)

Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
por: Saggam, Akash, et al.
Publicado: (2022)

Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients
por: Kuriakose, Jolly, et al.
Publicado: (2022)

Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
por: Brugnatelli, S., et al.
Publicado: (1996)

Chinese Herbal Medicine for Myelosuppression Induced by Chemotherapy or Radiotherapy: A Systematic Review of Randomized Controlled Trials
por: Jia, Youji, et al.
Publicado: (2015)

The efficacy of dietary Spirulina as an adjunct to chemotherapy to improve immune function and reduce myelosuppression in patients with malignant tumors
por: Ge, Yang, et al.
Publicado: (2019)

Traditional Chinese medicine on treating myelosuppression after chemotherapy: A protocol for systematic review and meta-analysis
por: Yang, Sihang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k9pnvjv7eedcnvib1cuq1bn940